Two more patients die in trial of Juno's JCAR015
Two more patients have died during a trial of Juno Therapeutics’ candidate white blood cell cancer therapy, JCAR015.
Two more patients have died during a trial of Juno Therapeutics’ candidate white blood cell cancer therapy, JCAR015.
Evonik has laid plans to expand a polymer facility in Alabama to cater for growing demand for sophisticated drug delivery and medical devices.
Holiday drug and API thefts are becoming less frequent but pharmaceutical firms still need to take precautions this Thanksgiving say experts.
A plan to attract advanced medicinal therapy manufacturing to the UK has emphasised the importance of the MHRA having a leading role in development of global regulatory standards.
While the temperature is dropping outside, keeping clinical trial therapeutics and biospecimens at the right temperature during transportation is a challenge year-round.
The full accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council is the company’s fourth as it looks to have all of its sites accredited.
Sun Pharma has announced it will buy a controlling interest in Russian drug and API manufacturer JSC Biosintez to access local market.
The acquisition of a stick sachet packaging line from Merz expands Almac Group’s MHRA/FDA-approved UK commercial packaging facility to meet the growing demand for specialist packing solutions.